Skip to main content
Y.S.H. logo

Y.S.H. — Investor Relations & Filings

Ticker · 3705 ISIN · TW0003705000 TW Financial and insurance activities
Filings indexed 2,128 across all filing types
Latest filing 2025-02-10 Regulatory Filings
Country TW Taiwan
Listing TW 3705

About Y.S.H.

www.yungshingroup.com

YungShin Global Holding Corporation is an investment holding company focused on the pharmaceutical and comprehensive healthcare sectors. Through its subsidiaries, the group manages an integrated value chain that spans research and development, manufacturing, and global distribution. Its diverse product portfolio includes human prescription and over-the-counter generic medicines, active pharmaceutical ingredients (APIs), animal health products, and health supplements. The company also provides cosmetics and specialty chemicals. Leveraging advanced enterprise resource planning systems to ensure operational transparency and quality control, the group serves a broad international market. Its core mission centers on delivering holistic health solutions and maintaining a robust presence across the healthcare supply chain, supported by a long-standing commitment to social welfare and community health initiatives.

Recent filings

Filing Released Lang Actions
114年1月營業收入
Regulatory Filings Classification · 90% confidence The document is very short (415 characters) and contains a summary table of company codes and names, along with a note about monthly revenue reporting by subsidiaries under ROC or IFRS standards. There is no detailed financial data, no mention of a specific report, no regulatory certification, or announcement of voting results. The content appears to be a general regulatory disclosure or summary information rather than a full report or announcement. Given the lack of detailed financial statements or specific report references, and the nature of the content as a general information summary, the best fit is Regulatory Filings (RNS).
2025-02-10 Chinese
114年01月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, chairman, independent directors, and senior management, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider shareholdings and transactions, which is typical of a Director's Dealing report. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but a detailed disclosure of insider shareholdings. Therefore, the document fits the category of Director's Dealing (DIRS).
2025-02-06 Chinese
114年01月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed disclosure of shareholdings and pledged shares by company insiders, including directors and senior management. It lists share counts, pledged shares, and related ratios for various insiders. The content focuses on insider shareholdings and pledges rather than financial results, management changes, or other corporate events. This type of document aligns with reporting of personal share transactions or holdings by company directors and executives. Given the nature of the data and the focus on insider holdings, the document fits best under the category 'Director's Dealing' (DIRS). The document length is 2326 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report.
2025-02-06 Chinese
113年12月營業收入
Regulatory Filings Classification · 90% confidence The document is very short (415 characters) and consists mainly of a summary table listing company codes and names, along with a note about monthly revenue reporting by subsidiaries under ROC or IFRS standards. There is no detailed financial data, no mention of a specific report, no regulatory certification, or any announcement of voting results or management changes. The content appears to be a general regulatory disclosure or summary information rather than a formal report or announcement. Given the lack of specific report content and the nature of the text, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other categories.
2025-01-10 Chinese
113年12月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 永信, providing data on loan balances and endorsement guarantees for the current and previous months. It contains no detailed financial statements, management discussion, or regulatory certifications. The length is very short (619 characters), and it appears to be a routine regulatory disclosure of financial guarantees and related party transactions. There is no indication that this is a full report, audit, or earnings release. It fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2025-01-10 Chinese
113年12月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed disclosure of shareholdings and pledged shares by company insiders, including directors and senior management. It lists the number of shares held, pledged shares, and related ratios for various insiders. The document does not contain financial statements, earnings data, or management discussion. It is a regulatory disclosure related to insider shareholdings and pledges, which fits the category of Director's Dealing (DIRS) as it reports personal share transactions or holdings by company directors and executives. The document length is short (2326 characters), but it contains substantive data on insider holdings rather than just an announcement or certification. Therefore, the appropriate classification is DIRS with high confidence.
2025-01-09 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.